Attention deficit hyperactivity disorder in prison.
Ghanizadeh
Ahmad
A
Akhondzadeh
Shahin
S
D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D011329:Prisoners / Q000331:legislation & jurisprudence* / Q000523:psychology*; D011437:Propylamines / Q000009:adverse effects / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000517:prevention & control*
D000697:Central Nervous System Stimulants; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride